These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9474068)

  • 1. Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography.
    Demissie K; Mills OF; Rhoads GG
    J Clin Epidemiol; 1998 Feb; 51(2):81-91. PubMed ID: 9474068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing the benefits of screening mammography for women 40-49 years old.
    Bastardis-Zakas K; Iatrakis G; Navrozoglou I; Peitsidis P; Salakos N; Malakassis P; Zervoudis S
    Clin Exp Obstet Gynecol; 2010; 37(4):278-82. PubMed ID: 21355457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of screening mammography. A meta-analysis.
    Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
    JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials.
    Hendrick RE; Smith RA; Rutledge JH; Smart CR
    J Natl Cancer Inst Monogr; 1997; (22):87-92. PubMed ID: 9709282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
    MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
    Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.
    Alexander FE; Anderson TJ; Brown HK; Forrest AP; Hepburn W; Kirkpatrick AE; Muir BB; Prescott RJ; Smith A
    Lancet; 1999 Jun; 353(9168):1903-8. PubMed ID: 10371567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study design of randomized controlled clinical trials of breast cancer screening.
    Paci E; Alexander FE
    J Natl Cancer Inst Monogr; 1997; (22):21-5. PubMed ID: 9709270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Edinburgh Randomized Trial of Breast Cancer Screening.
    Alexander FE
    J Natl Cancer Inst Monogr; 1997; (22):31-5. PubMed ID: 9709272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
    Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
    Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness: the next question for breast cancer screening.
    Harris R
    J Natl Cancer Inst; 2005 Jul; 97(14):1021-3. PubMed ID: 16030293
    [No Abstract]   [Full Text] [Related]  

  • 15. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
    Duijm LE; Guit GL; Zaat JO
    Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of breast cancer screening by mammography in younger women.
    Elwood JM; Cox B; Richardson AK
    Online J Curr Clin Trials; 1993 Feb; Doc No 32():[23,227 words; 195 paragraphs]. PubMed ID: 8305999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis adjusting for compliance: the example of screening for breast cancer.
    Glasziou PP
    J Clin Epidemiol; 1992 Nov; 45(11):1251-6. PubMed ID: 1432006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials.
    Smart CR; Hendrick RE; Rutledge JH; Smith RA
    Cancer; 1995 Apr; 75(7):1619-26. PubMed ID: 8826919
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.